Back
Defiance Daily Target 2X Lng Uranium ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Sell
1
URAX
Defiance Daily Target 2X Lng Uranium ETF
Last Price:
12.13
Seasonality Move:
--
Sell
44
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
68.77
Seasonality Move:
2.56%
Sell
1
Defiance Daily Target 2X Lng Uranium ETF (URAX)
is a Sell
Is Defiance Daily Target 2X Lng Uranium ETF a Buy, Sell or Hold?
- The current Defiance Daily Target 2X Lng Uranium ETF [URAX] share price is $11.28. The Score for URAX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- URAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $66.68. The Score for BIB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URAX Stock Price Chart
What is Defiance Daily Target 2X Lng Uranium ETF's stock price today?
-
The Defiance Daily Target 2X Lng Uranium ETF share price today is $11.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URAX is experiencing selling pressure, which indicates risk of future bearish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $66.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
URAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 45.76 | Sell |
| Chaikin Money Flow: | -2470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.71 - 12.47) | Sell |
| Bollinger Bands (100): | ( - ) | Buy |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 55.48 | Buy |
| Chaikin Money Flow: | -8699 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.16 - 67.46) | Buy |
| Bollinger Bands (100): | (56.44 - 65.98) | Buy |
URAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.2 | Buy |
| 20-day SMA: | 11.52 | Sell |
| 50-day SMA: | 12.88 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 11.31 | Sell |
| 20-day EMA: | 11.5 | Sell |
| 50-day EMA: | 9.05 | Buy |
| 200-day EMA: | 3.71 | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.98 | Buy |
| 20-day SMA: | 66.07 | Buy |
| 50-day SMA: | 65.28 | Buy |
| 200-day SMA: | 58.39 | Buy |
| 8-day EMA: | 66.31 | Buy |
| 20-day EMA: | 65.73 | Buy |
| 50-day EMA: | 64.37 | Buy |
| 200-day EMA: | 59.12 | Buy |
Defiance Daily Target 2X Lng Uranium ETF Earnings Growth & URAX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Defiance Daily Target 2X Lng Uranium ETF Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||